Rankings
▼
Calendar
HOTH Q3 2021 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOTH
Hoth Therapeutics, Inc.
$15M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-3.45
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$40,430
Balance Sheet
Total Assets
$15M
Total Liabilities
$2M
Stockholders' Equity
$13M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$3M
-$2M
-50.1%
Net Income
-$3M
-$2M
-55.7%
← FY 2021
All Quarters
Q4 2021 →